Relay Therapeutics operates under the executive leadership of Dr. Sanjiv K. Patel, who serves as the President and Chief Executive Officer. Bringing over two decades of extensive biopharmaceutical industry experience—including prior executive leadership roles at major global health enterprises—he directs the company's overarching corporate strategy and clinical pipeline development. His team oversees the advancement of novel therapeutic candidates derived from the company's proprietary motion-based drug discovery platform.